[Edaily Starin Gim Ga Yeong Reporter] Actress Jo Yeon-ji has signed an exclusive contract with Lead Entertainment.
Ikkul Entertainment announced on the 18th that it had signed an exclusive contract with Jo Yeon-ji. Jo Yeon-ji has been making a name for herself in the “short-form” market, starring as the female lead in the VIGLOO original series *Falling into a Fierce Love* and *My Unspeakable Bride*, which recently swept the No. 1 and No. 2 spots in viewership rankings across 19 countries worldwide—including South Korea—on the global short-form drama platform VIGLOO. “Falling into a Fierce Love” is a drama that follows the events that unfold after genius designer Yoon Jae-i, in order to single-handedly cope with her father’s gambling debts, her family’s downfall, and the child she is carrying, pushes her beloved boyfriend Lee Tae-bin away with a cruel lie and coldly breaks up with him. In this series, Jo Yeon-ji starred as the protagonist, Yoon Jae-i. “My Unspeakable Bride” is a romance of regret featuring Ha-na, who lost everything due to a hellish marriage, and Min-woo, who belatedly finds true love. In this drama, Jo Yeon-ji starred as Kang Ha-na. A representative from Ikkul Entertainment stated, “Jo Yeon-ji is a ‘ready-made next-generation star’ who possesses a trendy sensibility, solid acting skills, and a unique charm that draws you in the more you watch her,” adding, “We will spare no effort in providing full support so that she, with her limitless potential, can fully showcase her talents not only in short-form content but also across various platforms, including the big screen, television, and online video services (OTT).” Ikkul Entertainment represents actors including Ji Jin-hee, Baek Ji-won, Baek Hyun-ju, Lee Min-jae, Choi Jeong-woon, Lee Ji-won, Choi Won-myeong, Do Geon-woo, Bang Eun-jeong, and Jeong So-ri.
Personal information leaks are occurring simultaneously across the banking sector due to attacks by hackers.
A view of Hana Bank’s headquarters. (Photo courtesy of Hana Bank)
Hana Bank announced…
As an era dawns in which artificial intelligence (AI) designs hundreds of thousands of new drug candidates, wet labs—which validate these candidates through actual experiments—are emerging as a new bo…
“The approach of chasing targets that have already been validated by others no longer suits the Korean biotech industry.”Yoon Tae-young, CEO of OSCOTEC Inc., made this remark during a separate intervi…